Building the Foundations for Proactive Drug Safety - Qinecsa

Building the Foundations for Proactive Drug Safety

Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she outlines how proactive PV, translational safety, AI foundations, and ecosystem collaboration will reshape drug safety in 2026.

Read article

Recent Articles

The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?

Embracing quantitative signal detection methods as a smaller MAH

Real-Time Safety Signals Drive Continuous PV Insight

From Complaint Handling to Active Surveillance

Continuous Safety Surveillance for Medical Devices

Are patient outcomes getting lost in safety data complexity?

Previous Why Data, Trust, and Skills Are the Foundations of AI-Driven Pharmacovigilance

Next Future Ready Pharmacovigilance: When and Why to Outsource